DealMakerz

Complete British News World

Now the EU and Astra Geneca are meeting in court

Now the EU and Astra Geneca are meeting in court

EU wonders, among other things, how Astra Geneca used 22 224 million, just over 2 billion Swedish kronor, to pay the EU for the production of vaccines.

Europe’s own vaccine

The Swedish-British Astra Geneca vaccine has long been considered the main vaccine for Europe. However, this is not the case for a number of reasons. The EU says it has received promises to deliver 300 million doses from December 2020 to June 2021. In the first quarter of 2021, only 30 million doses were given instead of the 120 million promised by the EU. The company says it will not be able to deliver less than half of the amount promised for June.

To pay the fine

The EU has accused Astra Geneca of refusing to supply two of its UK manufacturers to the EU. The union believes large sums have been paid to contribute to securing production and increasing supply capacity. The EU has said the company will have to pay a fine if it does not comply with its final deliveries in mid-June.

On Wednesday, Astra will be questioned in Geneca court. The company has consistently denied allegations of breach of contract and called the allegations “unsubstantiated.” The court will announce the verdict within a few days.

READ  Vaccine success in the UK